Ronnie Moas Makes a Case for Rebound in Chinese Social Networking Firm Momo Inc
Standpoint Research Moves to Sidelines as DSW Delivers Upbeat Earnings
Standpoint Research’s top analyst Ronnie Moas was out pounding the table on Opko Health Inc. (NASDAQ:OPK) Friday, reiterating a Buy rating and price target of $14.
From August 23, 2010, top analyst Ronnie Moas at Standpoint Research has advocated confidence in Bank of America Corp (NYSE:BAC). Furthermore, ever since …
McKesson Corporation (NYSE:MCK) shares crashed over 20% today after the health care company reported disappointing results for the fiscal second-quarter and issued lackluster guidance. MCK posted …
Twitter Inc (NYSE:TWTR) shares jumped nearly 25% following the rumors that Salesforce.com and Google have expressed interest in a possible buyout of the struggling social …
Tesla Motors Inc Yesterday evening, Standpoint analyst Ronnie Moas downgraded shares of Tesla Motors Inc (NASDAQ:TSLA) from Hold to Sell, with a price target of …